Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
0 (Unchanged) |
Filing History |
| 2024-11-04 10:20 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
The Vanguard Group | 6,864,137 6.830% |
6,864,137 (New Position) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
4,005,535 (+105.72%) |
Filing History |
| 2024-04-04 7:04 pm Purchase |
2024-03-25 | 13G | Dyne Therapeutics, Inc. DYN |
RA CAPITAL MANAGEMENT L.P. | 5,213,661 6.400% |
5,213,661 (New Position) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,072,587 5.000% |
91,263 (+3.06%) |
Filing History |
| 2024-02-14 08:39 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-2,500,000 (-55.56%) |
Filing History |
| 2024-02-12 4:06 pm Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% |
-1,519,596 (-30.57%) |
Filing History |
| 2024-02-09 4:09 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,342,083 9.100% |
15,966 (+0.22%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
3,788,682 6.200% |
1,195,158 (+46.08%) |
Filing History |
| 2024-01-19 4:38 pm Purchase |
2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 4,500,000 5.550% |
2,500,000 (+125.00%) |
Filing History |
| 2024-01-19 09:08 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-684,200 (-25.49%) |
Filing History |
| 2023-02-14 4:29 pm Unchanged |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,326,117 14.100% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:53 pm Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,150,000 4.100% |
-804,392 (-27.23%) |
Filing History |
| 2023-02-14 08:32 am Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,684,200 5.150% |
-132,750 (-4.71%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,981,324 5.700% |
116,524 (+4.07%) |
Filing History |
| 2023-02-10 4:31 pm Sale |
2022-08-15 | 13D | Dyne Therapeutics, Inc. DYN |
Vida Ventures II, LLC | 2,220,034 4.300% |
-740,012 (-25.00%) |
Filing History |
| 2023-02-09 4:04 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 4,970,899 9.500% |
19,596 (+0.40%) |
Filing History |
| 2023-02-09 11:01 am Sale |
2023-01-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,593,524 4.900% |
-25,094 (-0.96%) |
Filing History |
| 2023-02-08 2:57 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,618,618 5.000% |
2,618,618 (New Position) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN |
RA CAPITAL MANAGEMENT L.P. | 0 0.000% |
-2,805,045 (Position Closed) |
Filing History |